• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?

作者信息

Bielinski S J, St Sauver J L, Olson J E, Wieland M L, Vitek C R, Bell E J, Mc Gree M E, Jacobson D J, McCormick J B, Takahashi P Y, Black J L, Caraballo P J, Sharp R R, Beebe T J, Weinshilboum R M, Wang L, Roger V L

机构信息

Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.

出版信息

Pharmacogenomics J. 2017 Jan;17(1):1-3. doi: 10.1038/tpj.2016.72. Epub 2016 Oct 25.

DOI:10.1038/tpj.2016.72
PMID:27779246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5310981/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/5310981/55a4d8761e6e/nihms813232f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/5310981/55a4d8761e6e/nihms813232f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/5310981/55a4d8761e6e/nihms813232f1.jpg

相似文献

1
Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?患者愿意为药物基因组学检测支付自付费用吗？
Pharmacogenomics J. 2017 Jan;17(1):1-3. doi: 10.1038/tpj.2016.72. Epub 2016 Oct 25.
2
Medical home and out-of-pocket medical costs for children with special health care needs.有特殊医疗需求儿童的医疗之家和自付医疗费用。
Pediatrics. 2011 Nov;128(5):892-900. doi: 10.1542/peds.2010-1307. Epub 2011 Oct 17.
3
National health expenditures, 1994.1994年国家卫生支出
Health Care Financ Rev. 1996 Spring;17(3):205-42.
4
Access to rural mental health services: service use and out-of-pocket costs.农村心理健康服务的可及性：服务利用和自付费用。
J Rural Health. 2010 Summer;26(3):214-24. doi: 10.1111/j.1748-0361.2010.00291.x.
5
By the numbers. Healthcare economics.从数据看。医疗保健经济学。
Mod Healthc. 2002 Dec 23;Suppl:2, 4, 6-7.
6
Business, households, and governments: health care costs, 1990.企业、家庭和政府：1990年的医疗保健费用
Health Care Financ Rev. 1991 Winter;13(2):83-93.
7
Business, households, and government: health care spending, 1995.企业、家庭与政府：1995年的医疗保健支出
Health Care Financ Rev. 1997 Spring;18(3):195-206.
8
Trends in out-of-pocket spending on health care, 1980-92.1980 - 1992年医疗保健自费支出趋势。
Mon Labor Rev. 1995 Dec;118(12):35-45.
9
The Medical Expenditure Panel Survey: an overview.医疗支出小组调查概述
Eff Clin Pract. 2002 May-Jun;5(3 Suppl):E1.
10
Out-of-pocket health care costs.自付医疗费用。
CMAJ. 2001 Jan 23;164(2):252.

引用本文的文献

1
Analyzing pharmacogenetics cost effectiveness and savings across common health conditions in the United States.分析美国常见健康状况下药物遗传学的成本效益及节省情况。
Pharmacogenomics J. 2025 Jul 8;25(4):18. doi: 10.1038/s41397-025-00376-z.
2
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data.实施药物遗传学护照的障碍与促进因素：从重新利用测序数据中汲取的经验教训
Pharmacogenomics. 2025 Apr-Apr;26(5-6):143-156. doi: 10.1080/14622416.2025.2504862. Epub 2025 May 21.
3
A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study).

本文引用的文献

1
Ethical, legal and social implications of incorporating personalized medicine into healthcare.将个性化医疗纳入医疗保健的伦理、法律和社会影响。
Per Med. 2015;12(1):43-51. doi: 10.2217/pme.14.65.
2
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.eMERGE-PGx项目的设计与预期成果：电子健康记录系统中抢先式药物基因组学的多中心试点项目
Clin Pharmacol Ther. 2014 Oct;96(4):482-9. doi: 10.1038/clpt.2014.137. Epub 2014 Jun 24.
3
Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
一项关于在新加坡门诊诊所实施先发制药物基因组学检测的可行性研究（IMPT研究）。
Pharmacogenomics J. 2025 Mar 12;25(1-2):7. doi: 10.1038/s41397-025-00366-1.
4
Patients' Experiences of a Precision Medicine Clinic.患者对精准医学诊所的体验。
J Patient Exp. 2024 Feb 1;11:23743735241229384. doi: 10.1177/23743735241229384. eCollection 2024.
5
Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States.美国一家三级学术医疗中心的药物遗传学检测报销情况。
Front Pharmacol. 2023 Aug 14;14:1179364. doi: 10.3389/fphar.2023.1179364. eCollection 2023.
6
Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved.探索医疗服务不足人群对药物遗传学检测的认知、知识和态度。
Front Genet. 2023 Jan 13;13:1085994. doi: 10.3389/fgene.2022.1085994. eCollection 2022.
7
A Theory-Informed Systematic Review of Barriers and Enablers to Implementing Multi-Drug Pharmacogenomic Testing.一项关于实施多药药物基因组检测的障碍与促进因素的理论导向性系统评价
J Pers Med. 2022 Nov 2;12(11):1821. doi: 10.3390/jpm12111821.
8
Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota.明尼苏达州公众对药物基因组检测及建立全州药物基因组数据库的态度。
J Pers Med. 2022 Sep 30;12(10):1615. doi: 10.3390/jpm12101615.
9
Public perceptions of pharmacogenomic services in Ireland - Are people with chronic disease more likely to want service availability than those without? A questionnaire study.爱尔兰公众对药物基因组学服务的看法——慢性病患者比非慢性病患者更希望获得该服务吗？一项问卷调查研究。
Explor Res Clin Soc Pharm. 2022 Sep 21;8:100182. doi: 10.1016/j.rcsop.2022.100182. eCollection 2022 Dec.
10
Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.预先的药物遗传学检测以指导胃肠道恶性肿瘤患者的化疗剂量：实施障碍的定性研究。
BMC Cancer. 2022 Jan 8;22(1):47. doi: 10.1186/s12885-022-09171-6.
个体化医学的预先基因分型：利用基因组数据制定正确的药物、正确的剂量、正确的治疗方案以实现个体化治疗。
Mayo Clin Proc. 2014 Jan;89(1):25-33. doi: 10.1016/j.mayocp.2013.10.021.
4
Genome science and health disparities: a growing success story?基因组科学与健康差异：一个日益成功的故事？
Genome Med. 2013 Jul 29;5(7):61. doi: 10.1186/gm465. eCollection 2013.
5
Gene-environment interactions and health inequalities: views of underserved communities.基因-环境相互作用与健康不平等：弱势群体的观点
J Community Genet. 2013 Oct;4(4):425-34. doi: 10.1007/s12687-013-0143-3. Epub 2013 Mar 15.
6
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.前瞻性个体化医疗基因分型的实施：范德堡 PREDICT 项目的设计。
Clin Pharmacol Ther. 2012 Jul;92(1):87-95. doi: 10.1038/clpt.2011.371. Epub 2012 May 16.
7
Cost effectiveness of pharmacogenomics: a critical and systematic review.药物基因组学的成本效益：批判性和系统性综述。
Pharmacoeconomics. 2010;28(11):1001-13. doi: 10.2165/11537410-000000000-00000.
8
Personalized medicine: factors influencing reimbursement.个性化医学：影响报销的因素。
Health Policy. 2010 Feb;94(2):91-100. doi: 10.1016/j.healthpol.2009.09.006. Epub 2009 Oct 7.
9
Medical advances and racial/ethnic disparities in cancer survival.医学进步与癌症存活率的种族/民族差异。
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2701-8. doi: 10.1158/1055-9965.EPI-09-0305. Epub 2009 Sep 29.
10
Effect of financial strain on mortality in community-dwelling older women.经济压力对社区老年女性死亡率的影响。
J Gerontol B Psychol Sci Soc Sci. 2008 Nov;63(6):S369-74. doi: 10.1093/geronb/63.6.s369.